Santhera Pharmaceuticals Holding AG
SIX:SANN
Santhera Pharmaceuticals Holding AG
Cash from Operating Activities
Santhera Pharmaceuticals Holding AG
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
S
|
Santhera Pharmaceuticals Holding AG
SIX:SANN
|
Cash from Operating Activities
-CHf29.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
ADC Therapeutics SA
NYSE:ADCT
|
Cash from Operating Activities
-$118.7m
|
CAGR 3-Years
11%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Cash from Operating Activities
-$260.4m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Cash from Operating Activities
CHf14.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Idorsia Ltd
SIX:IDIA
|
Cash from Operating Activities
-CHf859.1m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Kuros Biosciences AG
SIX:KURN
|
Cash from Operating Activities
-CHf8.8m
|
CAGR 3-Years
1%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
See Also
What is Santhera Pharmaceuticals Holding AG's Cash from Operating Activities?
Cash from Operating Activities
-29.8m
CHF
Based on the financial report for Dec 31, 2022, Santhera Pharmaceuticals Holding AG's Cash from Operating Activities amounts to -29.8m CHF.
What is Santhera Pharmaceuticals Holding AG's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
6%
Over the last year, the Cash from Operating Activities growth was 20%.